Literature DB >> 2224230

Captopril and systemic lupus erythematosus syndrome.

C Sieber1, E Grimm, F Follath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2224230      PMCID： PMC1663886          DOI： 10.1136/bmj.301.6753.669

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Hypotensive agents, beta-blockers, and drug-induced lupus.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

2.  Captopril-associated agranulocytosis.

Authors:  P van Brummelen; R Willemze; W D Tan; J Thompson
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

3.  Captopril associated granulocytopenia in hypertension after renal transplantation.

Authors:  F Elijovisch; L R Krakoff
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

Review 4.  Drug-induced systemic lupus erythematosus. Differentiating it from the real thing.

Authors:  S A Kale
Journal:  Postgrad Med       Date:  1985-02-15       Impact factor: 3.840

5.  Lupus erythematosus-like eruption from captopril.

Authors:  P Patri; A Nigro; A Rebora
Journal:  Acta Derm Venereol       Date:  1985       Impact factor: 4.437

6.  Captopril-associated granulocytopenia in hypertension after renal transplantation.

Authors:  K Shindo; F Matsuya; T Ura; A Jodai; H Shimomae; M Kuniyoshi; T Hirose; Y Kusaba; Y Saito
Journal:  Clin Nephrol       Date:  1984-12       Impact factor: 0.975
  6 in total
  3 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  Low-grade fever after prosthetic valve insertion and captopril therapy: an iatrogenic cause.

Authors:  M C Bialas; H Varley; H G Shetty; P A Routledge
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

3.  Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals.

Authors:  C Odaka; T Mizuochi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.